Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STOCKLAND Director's Dealing 2015

Mar 4, 2015

65781_rns_2015-03-04_7f1ae840-7492-4640-93ba-1fc564938268.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity STOCKLAND
(Joint listing of Stockland Corporation Limited and Stockland Trust)
ABN Stockland Corporation Limited - 43 000 181 733
Stockland Trust - 12 706 208 920

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mark Andrew Steinert
Date of last notice 28 November 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Name of Holder: Madison Way
Superannuation Fund
Nature of
Director and
Interest:
Beneficiary
Date of change 27 February 2015
No. of securities held prior to change Issued Securities:
555,620 comprising:
Mr Mark Steinert: 485,571
Madison Way
Superannuation Fund: 70,049
Performance Rights:
Mark Steinert: 2,254,000
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class Ordinary Stapled Securities
Number acquired 15,397 Ordinary Stapled Securities
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
$4.33 per security acquired
No. of securities held after change Issued Securities:
571,017 comprising:
Mr Mark Steinert: 499,027
Madison Way
Superannuation Fund: 71,990
Performance Rights:
Mark Steinert: 2,254,000
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Issued Securities:
Acquisition of securities issued under
the Dividend/Distribution Reinvestment
Plan (DRP).

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not Applicable
Nature of interest Not Applicable
Name of registered holder
(if issued securities)
Not Applicable
Date of change Not Applicable
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to
which the interest has changed
Not Applicable
Interest acquired Not Applicable
Interest disposed Not Applicable
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Not Applicable
Interest after change Not Applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
**clearance was required? **
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
Not Applicable
If prior written clearance was provided, on what date was this
provided?
Not Applicable
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3